A review on novel vesicular drug delivery: proniosomes

References

• Abd-Elbary A, El-laithy MI, Tadros HM. (2008). Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. Int J Pharm 357:189–98
   PubMed Web of Science ®Google Scholar
• Adnan A, Nilu J, Zeenat I, et al. (2008). Feasibility of proniosomes-based transdermal delivery of frusemide: formulation optimization and pharmacotechnical evaluation. Pharm Dev Technol 13:155–63
   PubMed Web of Science ®Google Scholar
• Ajay S, Jolly P, Rajesh P. (2008). Preparation, characterization, optimization, and stability studies of Aceclofenac Proniosomes. Iran J Pharm Res 7:237–46
   Web of Science ®Google Scholar
• Alsarra IA, Bosela AA, Ahmed SM, Mahrous GM. (2005). Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm 59:485–90
   PubMed Web of Science ®Google Scholar
• Ammara HO, Ghorabb M, El-Nahhasc SA, Higazya IM. (2011). Proniosomes as a carrier system for transdermal delivery of tenoxicam. Int J Pharm 405:142–52
   PubMed Web of Science ®Google Scholar
• Ankur G, Sunil KP, Balamurugan M, et al. (2007). Design and development of a proniosomal transdermal drug delivery system for captopril. Trop J Pharm Res 6:687–93
   Web of Science ®Google Scholar
• Azmin MN, Florence AT, Handjani-Vila RM, et al. (1985). The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice. J Pharm Pharmacol 37:237–42
   PubMed Web of Science ®Google Scholar
• Baillie A, Florence A, Hume L, et al. (1985). Preparation and properties of niosomes-nonionic surfactant vesicles. J Pharm Pharmacol 37:863–8
   PubMed Web of Science ®Google Scholar
• Bangham AD, Standish MM, Watkins JC. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238–52
   PubMed Web of Science ®Google Scholar
• Biju SS, Talegaonkar S, Misra PR, et al. (2006). Vesicular systems: an overview. Indian J Pharm Sci 68:141–53
   Google Scholar
• Blazek-Welsh AI, Rhodes DG. (2001a). Maltodextrin-based proniosomes. AAPS PharmSci Tech 3:1–8
   PubMed Web of Science ®Google Scholar
• Blazek-Welsh AI, Rhodes DG. (2001b). SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes. Pharm Res 18:656–61
   PubMed Web of Science ®Google Scholar
• Brinon L, Geiger S, Alard V, et al. (1999). Peercutaneous absorption of sunscreen from liquid crystalline phases. J Control Release 60:67–76
   PubMed Web of Science ®Google Scholar
• Carafa M, Santucci E, Lucania G. (2002). Lidocaine loaded non-ionic surfactant vesicles: characterization and in-vitro permeation studies. Int J Pharm 231:21–32
   PubMed Web of Science ®Google Scholar
• Charcosset C, Pham TT, Jaafar-Maalej C, et al. (2012). Liposome and niosome preparation using a membrane contactor for scale-up. Colloids Surf B 94:15–21
   PubMed Web of Science ®Google Scholar
• Chandraprakash KS, Udupa N, Umadevi P, et al. (1990). Pharmacokinetic evaluation of surfactant vesicles containing methotrexate in tumor bearing mice. Int J Pharm 61:R1–3
   Web of Science ®Google Scholar
• Chauhan S, Luorence MJ. (1989). The preparation of polyoxyethylene containing non-ionic surfactant vesicles. J Pharm Pharmacol 41:6--11
   Google Scholar
• Cioca G, James HA, Manuel LT, et al. (1991). Liquid crystal containing cosmetic US 4,999,348 issued 12 Mar 1991
   Google Scholar
• Devaraj GN, Parakh SR, Devraj R, et al. (2002). Release studies on Niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. J Colloid Interface Sci 251:360–5
   PubMed Web of Science ®Google Scholar
• El-Laithy HM, Shoukry O, Mahran LG. (2011). Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Biopharm 77:43–55
   PubMed Web of Science ®Google Scholar
• Fang JY, Yu SY, Wu PC, et al. (2001). In-vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 215:91–9
   PubMed Web of Science ®Google Scholar
• Gayatri DS, Venkatesh P, Udupa N. (2000). Niosomal sumatriptan succinate for nasal administration. Int J Pharm Sci 62:479–81
   Google Scholar
• Gibaldi M, Perrier D. (1982). Pharmacokinetics, 2nd ed. New York: Marcel Dekker
   Google Scholar
• Gupta A, Prajapati SK, Balamurugan M, et al. (2007). Design and development of a proniosomal transdermal drug delivery system for captopril. Trop J Pharm Res 6:687–93
   Web of Science ®Google Scholar
• Hao Y, Zhao F, Li N, et al. (2002). Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm 244:73–80
   PubMed Web of Science ®Google Scholar
• Hiremath PS, Soppimath KS, Betageri GV. (2009). Proliposomes of exemestane for improved oral delivery: formulation and in-vitro evaluation using PAMPA, Caco-2 and rat intestine. Int J Pharm 380:96–104
   PubMed Web of Science ®Google Scholar
• Hu C, Rhodes DG. (1999). Proniosomes: a novel drug carrier preparation. Int J Pharm 185:23–35
   PubMed Web of Science ®Google Scholar
• Iwai H, Fukasava J, Suzuki TA. (1998). Liquid crystal application in skin care cosmetics. Int J Cosmet Sci 20:87–102
   PubMedGoogle Scholar
• Katare OP, Vyas SP, Dixit VK. (1990). Effervescent granule based proliposomes of ibuprofen. J Microencapsul 7:455–62
   PubMed Web of Science ®Google Scholar
• Lieberman H, Lachman L, Schwartz J. (1990). Pharmaceutical dosage forms: tablets, Vol. 2, 2nd ed. New York: Marcel Decker, 229
   Google Scholar
• Malhotra M, Jain NK. (1994). Niosomes as drug carriers. Indian Drugs 31:81–6
   Google Scholar
• Mitsuno Y, Nomaguchi K, Suzuki T. (1988). Lamella type single phase liquid crystal composition and oil-base compositions using the same US 4,767,625 issued Aug 1988
   Google Scholar
• Mokhtar M, Sammour OA, Hammad MA, et al. (2008). Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 361:104–11
   PubMed Web of Science ®Google Scholar
• Muller RH, Radtke M, Wissing SA. (2002). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54:131–55
   PubMed Web of Science ®Google Scholar
• Namdeo A, Jain NK. (1999). Niosomal delivery of 5-fluorouracil. J Microencapsul 16:731–40
   PubMed Web of Science ®Google Scholar
• Payne NI, Browning I, Hynes CA. (1986). Characterization of proliposomes. J Pharm Sci 75:330–3
   PubMed Web of Science ®Google Scholar
• Perrett S, Golding M, Williams WP. (1991). A simple method for the preparation of liposomes for pharmaceutical applications: characterization of the liposomes. J Pharm Pharmacol 43:154–61
   PubMed Web of Science ®Google Scholar
• Puglia C, Trombetta D, Venuti V, et al. (2004). Evaluation of in vivo topical anti-inflammatory activity of indometacin from liposomal vesicles. J Pharm Pharmacol 56:1225–32
   PubMed Web of Science ®Google Scholar
• Raju J, Karthik YJ, Ashok V, et al. (2012). Bioavailability enhancement of zaleplon via proliposomes: Role of surface charge. Eur J Pharm Biopharm 80:347–57
   PubMed Web of Science ®Google Scholar
• Rentel CO, Bouwstra JA, Naisbett B, et al. (1999). Niosomes as a novel peroral vaccine delivery system. Int J Pharm 186:161–7
   PubMed Web of Science ®Google Scholar
• Ruckmani K, Jayakar B, Ghosal SK. (2002). Nonionic surfactant vesicles (niosomes) of cytarabine hydrochloride for effective treatment of leukemias: encapsulation, storage, and in-vitro release. Drug Dev Ind Pharm 26:217–22
   Web of Science ®Google Scholar
• Runothayanun P, Sooksawate T, Florence AT. (1999). Extrusion of niosomes from capillaries: approaches to pulsed delivery device. J Control Release 60:391–7
   PubMed Web of Science ®Google Scholar
• Saettone MF, Perini G, Carafa M, et al. (1996). Non-ionic surfactant vesicles as ophthalmic carriers for cyclopentolate. A preliminary evaluation. S.T.P Pharma Sci 6:94–8
   Web of Science ®Google Scholar
• Schreier H, Bouwstra J. (1994). Liposomes and niosomes as topical drug carriers-dermal and transdermal drug-delivery. J Control Release 30:1–15
   Web of Science ®Google Scholar
• Solanki AB, Parikh JR, Parikh RH. (2007). Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level box-behnken design. AAPS Pharm Sci Tech 8:E1–7
   PubMed Web of Science ®Google Scholar
• Tamizharasi S, Sunil B, Rathi V, et al. (2009). Formulation and evaluation of maltodextrin based proniosomes loaded with indomethacin. Int J Pharm Tech Res 13:517–23
   Google Scholar
• Thakur R, Anwer MK, Shams MS, et al. (2009). Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation. J Drug Target 17:442–9
   PubMed Web of Science ®Google Scholar
• Uchegbu IF, Double JA, Turton JA, et al. (1995). Niosome encapsulation of a doxorubicin polymer conjugates. Pharm Res 12:1019–24
   PubMed Web of Science ®Google Scholar
• Uchegbu IF, Florence AT. (1995). Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Adv Colloid Interface Sci 58:1–55
   Web of Science ®Google Scholar
• Uchegbu IF, Vyas SP. (1998). Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 172:33–70
   Web of Science ®Google Scholar
• Varshosa J, Pardhakhty A, Mohsen S, et al. (2005). Sorbitan monopalmitate-based proniosomes for transdermal delivery of chlorpheniramine maleate. Drug Deliv 12:75–82
   PubMed Web of Science ®Google Scholar
• Vora B, Khopade AJ, Jain NK. (1998). Proniosome based transdermal delivery of levonorgesterel for effective contraception. J Control Release 54:149–65
   PubMed Web of Science ®Google Scholar
• Vyas SP, Khar RK. (2002). Targeted and controlled drug delivery: novel carrier systems. New Delhi, India: CBS Publications
   Google Scholar
• Vyas SP, Mysore N, Jaittley V, et al. (1998). Discoidal niosome based controlled ocular delivery of timolol maleate. Pharmazie 53:466–9
   PubMed Web of Science ®Google Scholar
• Yoshioka T, Sternberg B, Florence AT. (1994). Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60, and 80) and a sorbitan triester (Span 85). Int J Pharm 105:1–6
   Web of Science ®Google Scholar